Stem Cell Transplant Achieves Long-Term HIV Remission in Oslo Patient

What's Happening? A 63-year-old Norwegian man, referred to as the 'Oslo patient,' has achieved long-term HIV remission following a stem cell transplant from his brother. The transplant was initially performed to treat a rare blood cancer, but it was discovered that the donor carried a rare genetic m

Summarized by AI ⓘ

Science Uncovered

SEE ALL

Rapid Read

TERI Demonstrates Biomass Gasifier for Clean Community Cooking, Reducing Fossil Fuel Dependence

Rapid Read

New Molecules Offer Hope for Treating Autoimmune Diseases

Rapid Read

Study Reveals Antiseptic Tolerance in Hospital Bacteria, Raising Concerns Over Antibiotic Resistance

What is the story about?

What's Happening?

A 63-year-old Norwegian man, referred to as the 'Oslo patient,' has achieved long-term HIV remission following a stem cell transplant from his brother. The transplant was initially performed to treat a rare blood cancer, but it was discovered that the donor

carried a rare genetic mutation, CCR5Δ32/Δ32, which is resistant to HIV. Four years post-transplant, all traces of functioning HIV DNA were cleared, and the patient was able to stop HIV medication two years after the procedure. This case adds to the limited number of documented HIV cure cases.

Why It's Important?

This case provides valuable insights into potential pathways for achieving an HIV cure. The genetic mutation in the donor's cells, which prevents HIV from entering immune cells, offers a unique opportunity to study the mechanisms behind HIV resistance. While stem cell transplants are not a practical cure for HIV due to their risks and complexity, understanding the factors that led to remission in this case could inform future research and treatment strategies. It highlights the importance of genetic factors in HIV treatment and the potential for personalized medicine approaches.